Related Experiment Video
Updated: Jun 2, 2026
09:27
New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
Patent data mining: a tool for accelerating HIV vaccine innovation.
K Clark1, J Cavicchi, K Jensen
1PIPRA, University of California, Davis, CA 95616, USA. kerri@pipra.org
Vaccine
|April 19, 2011
Summary
Analyzing patent landscapes is crucial for global vaccine access. Understanding intellectual property (IP) helps accelerate research, development, and delivery of vital vaccines like those for HIV.
Area of Science:
- Vaccinology
- Intellectual Property Law
- Biotechnology
Background:
- Global vaccine access is hindered by intellectual property (IP) management, technology transfer, and R&D capacity.
- Patents are an underutilized resource for scientific, business, and technological information, essential for strategic decision-making.
Purpose of the Study:
- To demonstrate the importance of patent landscape analysis for informed IP management strategies in vaccine development.
- To identify obstacles and opportunities in the development and deployment of vaccines, specifically for HIV.
Main Methods:
- Compilation and analysis of a representative HIV vaccine patent landscape.
- Focus on a prime-boost, DNA/adenoviral vaccine platform.
Main Results:
- Patent landscape analysis reveals critical information on patenting volume, ownership, and technological fields.
- Identified key factors for informed decision-making, including identifying licensees and collaborations.
Conclusions:
- Patent landscape analysis is fundamental for facilitating global vaccine access.
- Strategic IP management, informed by patent analysis, can accelerate the development and delivery of vaccines, particularly for challenging diseases like HIV.
